A Phase III, Open Label, Randomized, Controlled, Multi-c

Project: Research project

Project Details

Description

A Phase III, Open Label, Randomized, Controlled, Multi-center Study to assess the efficacy and safety of Olaparib Monotherapy versus Physician's Choice Chemotherapy of Metastatic Breast Cancer Patients with germline BRCA1/2 Mutations
StatusFinished
Effective start/end date6/1/146/30/19

Funding

  • AstraZeneca

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.